BUYINS.NET: Market Maker Surveillance Report. BBD, PFE, SIRI, INFA, CHTP, GBEN, Highest Net Sell Volume and Negative Price Friction For Friday, December 7th 2012
(M2 PressWIRE Via Acquire Media NewsEdge) BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Friday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Friday there were 4132 companies with "abnormal" market making, 2646 companies with positive Friction Factors and 2703 companies with negative Friction Factors. Here is a list of the top companies with the highest net sell volume on Friday and lowest negative price Friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. Banco Bradesco SA (NYSE:BBD), Pfizer Inc (NYSE:PFE), Sirius XM Radio Inc (NASDAQ:SIRI), INFORMATICA CORPORATION (NASDAQ:INFA), Chelsea Therapeutics International Ltd (NASDAQ:CHTP), (OTC:GBEN). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
Market Maker Friction Factor is shown in the chart below:
Symbol Change Percent Buy Volume Buy %% Sell Volume Sell %% Net Volume Friction
BBD $-0.080 -0.47% 2,019,852 22.11% 2,942,523 32.21% -922,671 -115,334
PFE $-0.050 -0.20% 8,105,358 26.50% 10,965,074 35.84% -2,859,716 -571,943
SIRI $-0.030 -1.08% 32,987,678 44.24% 41,450,734 55.59% -8,463,056 -2,821,019
INFA $-0.080 -0.32% 1,068,856 31.23% 2,353,177 68.76% -1,284,321 -160,540
CHTP $-0.100 -10.07% 1,051,679 31.63% 2,268,254 68.22% -1,216,575 -121,658
GBEN $-0.014 -23.73% 1,100,115 30.73% 2,479,878 69.27% -1,379,763 -985,545
Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have low price friction combined with more selling than buying (negative Net Volume) in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.
For example, the chart above shows BBD down $-0.08000 with a Friction Factor of -115,334 and a Net Volume of -922,671. That means that it takes 115,334 more shares of selling than buying to drop BBD by one penny. On Monday the Market Makers allowed the stock to move down on heavier selling than buying (low negative friction).
Banco Bradesco SA (NYSE:BBD) - Banco Bradesco S.A. provides a range of banking and financial products and services to individuals; large, small, and mid-sized companies; and local and international corporations and institutions. It operates in two business units, including Banking Services and Insurance Services, Pension Plans, and Certificated Savings Plans. The Banking Services business unit comprises deposit taking activities, including checking accounts, investment deposit accounts, savings accounts, time deposits, and interbank deposits; credit operations, such as individuals and companies, real estate financing, microcredit, onlending of BNDES resources, rural credit, and leasing; credit cards, debit cards, and pre paid cards; management of receipts, payments, human resources, and administrative support; asset management; services related to capital markets and investment banking activities; intermediation and trading services; custody, depositary, and controllership services; international banking services; and consortiums. The Insurance Services, Pension Plans, and Certificated Savings Plans unit offers various products and services, including life, personal accident, and random events insurance; health and dental care insurance; automobile insurance; property and casualty insurance; individual and corporate pension plans; certified savings plans; and pension investment contracts. As of December 31, 2009, Banco Bradesco S.A. operated a network of 3,454 branches, 30,657 ATMs, and 4,112 special banking service stations and outlets in Brazil. It also operated four branches and seven subsidiaries in New York, London, the Cayman Islands, the Bahamas, Japan, Hong Kong, Argentina, and Luxembourg. The company, formerly known as Banco Brasileiro de Descontos S.A., was founded in 1943 and is headquartered in Osasco, Brazil..
Pfizer Inc (NYSE:PFE) - Pfizer Inc., a biopharmaceutical company, offers prescription medicines for humans and animals worldwide. The company's Biopharmaceutical segments provides Lipitor for elevated LDL-cholesterol levels in the blood; Enbrel for rheumatoid arthritis, polyarticular juvenile rheumatoid arthritis, psoriatic arthritis, plaque psoriasis, and ankylosing spondylitis; Lyrica for post-herpetic neuralgia, diabetic peripheral neuropathy, fibromyalgia, neuropathic pain, adjunctive treatment of epilepsy, and general anxiety disorder, as well as for use as an adjunctive therapy for adult patients with partial onset seizures; Prevnar/Prevenar for invasive pneumococcal disease; Celebrex for osteoarthritis and rheumatoid arthritis, and acute pain; Viagra for erectile dysfunction; Xalabrands for reducing elevated eye pressure; Effexor XR for depressive, generalized anxiety, social anxiety, and panic disorders; and Norvasc for hypertension. It also offers Zyvox for gram-positive pathogens; Premarin for menopausal symptoms; Sutent for renal cell carcinoma; Geodon/Zeldox for schizophrenia; Detrol/Detrol LA for overactive bladder; Zosyn/Tazocin, an intravenous antibiotic; Genotropin for growth hormone deficiency; Vfend, an antifungal agent; and Protonix for gastroesophageal reflux disease; Chantix/Champix for aid smoking cessation; BeneFIX, ReFacto AF, and Xyntha for lifelong bleeding disorder; Caduet for cardiovascular events; Revatio for pulmonary arterial hypertension; Pristiq for depressive disorder; Aricept for Alzheimers disease; and Spiriva for breathing problems. The companys Diversified segment offers animal health products, such as vaccines, anti-infectives, anti-inflammatories, antiemetics, and parasiticides; consumer healthcare products, such as dietary supplements, pain management, respiratory, and personal care; nutrition products; and gelatin, liquid, softgel, non-animal, and fish gelatin capsules. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York..
Sirius XM Radio Inc (NASDAQ:SIRI) - Sirius XM Radio Inc. provides satellite radio services in the United States and Canada. The company offers a programming lineup of approximately 135 channels of commercial-free music, sports, news, talk, entertainment, and traffic and weather. It also provides music channels that offer music genres, ranging from rock, pop and hip-hop to country, dance, jazz, Latin, and classical; channels of sports; talk and entertainment channels; comedy channels; national, international, and financial news channels; and religious channels. As of December 31, 2009, Sirius XM Radio had 18,772,758 subscribers. In addition, it provides music services for commercial establishments; music and comedy channels to mobile phone users; and music channels and select non-music channels over the Internet; a suite of data services; services that offer graphic information; and various real-time weather services, as well as operates a television service, which provides content designed primarily for children in the backseat of vehicles. Further, the company engages in the distribution of satellite radios for use in cars, trucks, homes, offices, boats, or other locations. Sirius XM Radio distributes its satellite radios primarily through automakers, retailers, and Web sites, as well as offers to customers of rental car companies. Further, it provides home units that offer satellite services to home and commercial audio systems, and products that provide access to the Internet radio services in the home without the personal computer. The company was formerly known as Sirius Satellite Radio Inc. and changed its name to Sirius XM Radio Inc. in August 2008. Sirius XM Radio Inc. was founded in 1990 and is headquartered in New York, New York..
INFORMATICA CORPORATION (NASDAQ:INFA) - Informatica Corporation provides enterprise data integration and data quality software and services worldwide. Its software solutions include a set of technologies that enable various enterprise-wide data integration initiatives. The company offers PowerCenter, which integrates data virtually from business systems in various formats and delivers that data throughout the enterprise; PowerExchange that enables IT organizations to access the sources of enterprise data without having to develop custom data access programs; and Informatica Data Services for finding, integrating, and managing data across the enterprise. It also provides Data Quality, which delivers data quality to stakeholders, projects, and data domains; Master Data Management that provides consolidated business-critical data; and B2B Data Exchange software for multi-enterprise data integration. In addition, the company offers application information lifecycle management products to manage various phases of the data lifecycle, from development and testing to archiving and retirement; complex event processing to detect, correlate, analyze, and respond to data-driven events; Ultra Messaging products, which enables ultra low latency messaging; and Cloud that delivers purpose-built data integration cloud applications to allow business users to integrate data across cloud-based applications, and on-premise systems and databases. Further, it offers product-related customer support, consulting, and education services. Informatica Corporation serves aerospace, automotive, energy and utilities, entertainment/media, financial services, healthcare/life sciences, high technology, insurance, manufacturing, public sector, retail, services, telecommunications, and travel/transportation industries through its direct sales force, as well as through systems integrators, resellers, distributors, and original equipment manufacturer partners. The company was founded in 1993 and is headquartered in Redwood City, California..
Chelsea Therapeutics International Ltd (NASDAQ:CHTP) - Chelsea Therapeutics International, Ltd., a development stage pharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of various human diseases. The companys compounds target various prevalent medical conditions, primarily rheumatoid arthritis, psoriasis, cancer, other immunological disorders, and neurogenic orthostatic hypotension associated with Parkinsons disease and other autonomic disorders. It offers Droxidopa, an orally active synthetic precursor of norepinephrine for the treatment of symptomatic neurogenic orthostatic hypotension, freezing gait in Parkinsons disease, and intradialytic hypotension in Japan. The company develops droxidopa in three indications, such as neurogenic orthostatic hypotension, intradialytic hypotension, and fibromyalgia. It also develops a portfolio of molecules for the treatment of various autoimmune/inflammatory diseases, such as a portfolio of metabolically inert antifolate molecules, including CH-1504 for the treatment of rheumatoid arthritis that is in a phase II head-to-head clinical trial; and CH-4051, which completed the phase I study designed to determine the maximum tolerated dose based on results of single-ascending and multiple-ascending dose evaluations. In addition, the company develops antifolate program, a platform consisting of a portfolio of dihydroorotate dehydrogenase(DHODH), inhibiting compounds known as the I-3D portfolio, a group of orally active compounds that inhibit the enzyme DHODH for the treatment of autoimmune diseases and transplant rejection. Chelsea Therapeutics International, Ltd. was founded in 2002 and is headquartered in Charlotte, North Carolina..
(OTC:GBEN) - .
BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO
INVESTMENTS & TRADING
SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.
((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to firstname.lastname@example.org)).
(c) 2012 M2 COMMUNICATIONS
[ Satellite Spotlight's Homepage ]